108 related articles for article (PubMed ID: 35049168)
1. Efficacy and safety of Shenkang injection in the treatment of chronic renal failure: A protocol of a randomized controlled trial.
Mei J; Yang L; Wang D; Wang H
Medicine (Baltimore); 2021 Dec; 100(48):e27748. PubMed ID: 35049168
[TBL] [Abstract][Full Text] [Related]
2. Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients: A Randomized Controlled Trial.
Cao W; Liu L; Peng J; Li Y; Tian J; Gong D
J Integr Complement Med; 2023 Apr; 29(4):253-260. PubMed ID: 36944133
[No Abstract] [Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic modeling of the active components of Shenkang injection in rats with chronic renal failure and its protective effect on damaged renal cells.
Zhou L; Wang X; Xia J; Zhang L; Xue L; Jia Q; Fu Z; Sun Z
Biopharm Drug Dispos; 2023 Dec; 44(6):406-419. PubMed ID: 37679901
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Shenkang injection as adjuvant therapy in patients with diabetic nephropathy: A protocol for systematic review and meta-analysis.
Wang Y; Li M; Li C; Xu S; Wu J; Zhang G; Cai Y
Medicine (Baltimore); 2020 Dec; 99(52):e23821. PubMed ID: 33350769
[TBL] [Abstract][Full Text] [Related]
5. Shenkang injection combined with alprostadil for chronic renal failure: A systematic review and meta-analysis.
Xie F; Zhang T; Zhang P; Qu X; Li M; Lan W
Front Med (Lausanne); 2023; 10():982016. PubMed ID: 37089596
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Shenfu injection combined with sodium nitroprusside in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial.
Guo B; Yang T; Nan J; Huang Q; Wang C; Xu W
Medicine (Baltimore); 2021 Feb; 100(7):e24414. PubMed ID: 33607775
[TBL] [Abstract][Full Text] [Related]
7. [Shenshuaining capsules as adjuvant treatment for chronic renal failure: systematic review and Meta-analysis of randomized controlled trials].
Cui RZ; Xie YM; Liao X; Wang JD
Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(11):2149-2161. PubMed ID: 28901115
[TBL] [Abstract][Full Text] [Related]
8. [Effect of Shenkang Injection on Kidney Function in Hypertensive Renal Damage Rats].
Zhang Y; Zhou N; Li T; Wang HY; He JY
Zhong Yao Cai; 2014 Dec; 37(12):2248-54. PubMed ID: 26080514
[TBL] [Abstract][Full Text] [Related]
9. Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial.
Gao Y; Gao Y; Zhu R; Tan X
Medicine (Baltimore); 2021 Jan; 100(3):e24113. PubMed ID: 33546020
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
[TBL] [Abstract][Full Text] [Related]
11. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
Gan J; Wu Y; Gong X; Ma Y; Yu S; Gao J
Trials; 2019 Aug; 20(1):481. PubMed ID: 31391092
[TBL] [Abstract][Full Text] [Related]
12. Protective effect and mechanism of Shenkang injection on adenine-induced chronic renal failure in rats.
Chen R; Xu L; Zhang X; Sun G; Zeng W; Sun X
Acta Cir Bras; 2022; 37(3):e370304. PubMed ID: 35674582
[TBL] [Abstract][Full Text] [Related]
13. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
14. Renal Metabolomics Study and Critical Pathway Validation of Shenkang Injection in the Treatment of Chronic Renal Failure.
Zhou L; Wang X; Zhang Y; Xie Y; Cui R; Xia J; Sun Z
Biol Pharm Bull; 2024; 47(2):499-508. PubMed ID: 38382928
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Shaobei injection in the treatment of grade II-III hemorrhoids and the effect on fibulin protein expression: A study protocol of a randomized controlled trial.
Yue B; Wang Y; Zhang C; Ding Y; Liu Z
Medicine (Baltimore); 2021 Nov; 100(46):e27706. PubMed ID: 34797296
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Qingshen Granule on serum interleukin-8 and -18 levels in patients with a sharp deterioration of chronic renal failure and dampness-heat syndrome: a randomized controlled trial].
Wang F; Wang YP; Wang D; Cheng W; Hu SJ; Lu Y; Liu L
Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):328-31. PubMed ID: 20388472
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction: A single-center, double-blind, randomized controlled trial.
Yang Y; Gao S; Fang Q; Zhu M
Medicine (Baltimore); 2021 Jan; 100(3):e24246. PubMed ID: 33546045
[TBL] [Abstract][Full Text] [Related]
18. [Bayesian network Meta-analysis of Chinese medicine injections in treatment of chronic renal insufficiency].
Mo JH; Qi XJ; Xu HB; Zhou RJ; Xing WL; Mao W
Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(2):454-466. PubMed ID: 33645135
[TBL] [Abstract][Full Text] [Related]
19. Aqueous extract from You-Gui-Yin ameliorates cognitive impairment of chronic renal failure mice through targeting hippocampal CaMKIIα/CREB/BDNF and EPO/EPOR pathways.
Tang Q; Ke H; Wu C; Zeng J; Li Z; Liu Y; Feng S; Xue Q; Xu X
J Ethnopharmacol; 2019 Jul; 239():111925. PubMed ID: 31055001
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of Buzhong Yiqi Decoction in improving cancer-related fatigue and immunity of cervical carcinoma patients: A protocol of randomized controlled trial.
Hu J; Li X; Fang Y; Peng J
Medicine (Baltimore); 2021 Dec; 100(49):e27938. PubMed ID: 34889240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]